Gilead inks deal with biologics developer Tentarix co-founded by BC entrepreneurs

The U.S. drug giant will pay Tentarix Biotherapeutics Inc. US$66-million upfront and the pair will partner on three development programs

Related Keywords

Canada ,San Francisco ,California ,United States ,San Diego ,Vancouver ,British Columbia ,Canadian ,Flavius Martin ,Stephen Demarest ,Jerel Davis ,Michael Gallo ,Margaret Karow ,Paul Kang ,Paul Grayson ,Cell Genesys Inc ,Zymeworks Inc ,Tentarix Biotherapeutics Inc ,Gilead Sciences Inc ,Abcellera Biologics Inc ,Amgen Inc ,Innovative Targeting Solutions Inc ,Log Increate Free ,Abcellera Biologics ,Versant Ventures ,Cell Genesys ,San Francisco Based Versant ,Samsara Biocapital ,Streetwise ,Tentarix ,Inc ,Cells ,San ,Cell ,Gilead ,Technology ,Burnaby ,